Eventide Asset Management - Q2 2020 holdings

$4.6 Billion is the total value of Eventide Asset Management's 134 reported holdings in Q2 2020. The portfolio turnover from Q1 2020 to Q2 2020 was 29.5% .

 Value Shares↓ Weighting
ASND BuyASCENDIS PHARMA A Ssponsored adr$252,887,000
+32.2%
1,709,848
+0.7%
5.50%
-11.3%
SRPT  SAREPTA THERAPEUTICS INC$159,699,000
+63.9%
996,0000.0%3.47%
+10.0%
EXAS BuyEXACT SCIENCES CORP$151,276,000
+87.4%
1,740,000
+25.0%
3.29%
+25.8%
IGV BuyISHARES TRput$137,700,000
+122.2%
600,000
+106.2%
2.99%
+49.2%
BHVN  BIOHAVEN PHARMACTL HLDG CO L$130,411,000
+114.8%
1,783,7610.0%2.84%
+44.2%
FIVN SellFIVE9 INC$127,381,000
+36.8%
1,151,000
-5.5%
2.77%
-8.2%
TTD  THE TRADE DESK INC$121,950,000
+110.6%
300,0000.0%2.65%
+41.4%
W  WAYFAIR INCcl a$113,231,000
+269.8%
573,0000.0%2.46%
+148.1%
KRTX  KARUNA THERAPEUTICS INC$100,434,000
+54.8%
901,0770.0%2.18%
+3.9%
CRWD  CROWDSTRIKE HLDGS INCcl a$98,986,000
+80.1%
987,0000.0%2.15%
+20.9%
ROP BuyROPER TECHNOLOGIES INC$90,232,000
+35.2%
232,400
+8.6%
1.96%
-9.3%
PLRX NewPLIANT THERAPEUTICS INC$88,412,0002,838,125
+100.0%
1.92%
TWLO SellTWILIO INCcl a$84,696,000
+38.2%
386,000
-43.6%
1.84%
-7.3%
LOW BuyLOWES COS INC$81,058,000
+57.9%
599,900
+0.6%
1.76%
+6.0%
SPLK SellSPLUNK INC$75,506,000
+39.8%
380,000
-11.2%
1.64%
-6.2%
WCN  WASTE CONNECTIONS INC$75,407,000
+21.0%
804,0000.0%1.64%
-18.8%
DT SellDYNATRACE INC$75,090,000
+51.7%
1,849,500
-10.9%
1.63%
+1.8%
MTD BuyMETTLER TOLEDO INTERNATIONAL$73,305,000
+49.5%
91,000
+28.2%
1.59%
+0.4%
POOL BuyPOOL CORPORATION$67,750,000
+85.1%
249,200
+34.0%
1.47%
+24.3%
LRCX  LAM RESEARCH CORP$65,015,000
+34.8%
201,0000.0%1.41%
-9.5%
NEP BuyNEXTERA ENERGY PARTNERS LP$64,515,000
+20.7%
1,258,100
+1.2%
1.40%
-19.0%
ASML  ASML HOLDING N V$63,301,000
+40.7%
172,0000.0%1.38%
-5.6%
MYOK  MYOKARDIA INC$60,001,000
+106.1%
621,0000.0%1.30%
+38.3%
ARGX SellARGENX SEsponsored adr$59,461,000
+51.8%
264,000
-11.2%
1.29%
+2.0%
LII  LENNOX INTL INC$59,412,000
+28.2%
255,0000.0%1.29%
-13.9%
IDXX BuyIDEXX LABS INC$58,108,000
+67.7%
176,000
+23.1%
1.26%
+12.6%
SMAR BuySMARTSHEET INC$56,674,000
+44.2%
1,113,000
+17.5%
1.23%
-3.2%
GWPH  GW PHARMACEUTICALS PLCads$53,506,000
+40.1%
436,0000.0%1.16%
-5.9%
AIMT SellAIMMUNE THERAPEUTICS INC$53,357,000
-3.9%
3,193,117
-17.1%
1.16%
-35.5%
IPHI  INPHI CORP$52,875,000
+48.4%
450,0000.0%1.15%
-0.4%
ODFL BuyOLD DOMINION FREIGHT LINE IN$52,607,000
+87.7%
310,200
+45.3%
1.14%
+26.1%
HUBS SellHUBSPOT INC$52,049,000
+17.7%
232,000
-30.1%
1.13%
-21.0%
TREX BuyTREX CO INC$48,646,000
+103.0%
374,000
+25.1%
1.06%
+36.2%
VMC SellVULCAN MATLS CO$46,155,000
+6.3%
398,400
-0.8%
1.00%
-28.7%
RNG BuyRINGCENTRAL INCcl a$44,177,000
+72.3%
155,000
+28.1%
0.96%
+15.7%
CCI SellCROWN CASTLE INTL CORP NEW$44,080,000
+14.8%
263,400
-0.9%
0.96%
-22.9%
BEP  BROOKFIELD RENEWABLE PARTNERpartnership unit$43,886,000
+12.7%
916,2000.0%0.95%
-24.3%
NBIX BuyNEUROCRINE BIOSCIENCES INC$43,652,000
+42.9%
357,800
+1.4%
0.95%
-4.0%
ZNTL NewZENTALIS PHARMACEUTICALS INC$42,496,000914,705
+100.0%
0.92%
COLL  COLLEGIUM PHARMACEUTICAL INC$42,490,000
+7.2%
2,427,9760.0%0.92%
-28.0%
TT BuyTRANE TECHNOLOGIES PLC$41,999,000
+2468.7%
472,000
+2283.8%
0.91%
+1622.6%
APTV SellAPTIV PLC$41,843,000
+52.7%
537,000
-3.5%
0.91%
+2.6%
DHI BuyD R HORTON INC$40,490,000
+80.7%
730,200
+10.8%
0.88%
+21.2%
MNTA  MOMENTA PHARMACEUTICALS INC$40,323,000
+22.3%
1,212,0000.0%0.88%
-17.9%
VRSK BuyVERISK ANALYTICS INC$37,359,000
+69.6%
219,500
+38.9%
0.81%
+13.9%
KALA BuyKALA PHARMACEUTICALS INC$36,259,000
+39.7%
3,450,000
+16.8%
0.79%
-6.3%
BPMC  BLUEPRINT MEDICINES CORP$36,036,000
+33.4%
462,0000.0%0.78%
-10.5%
MRTX  MIRATI THERAPEUTICS INC$34,365,000
+48.5%
301,0000.0%0.75%
-0.3%
GBT  GLOBAL BLOOD THERAPEUTICS IN$33,775,000
+23.6%
535,0000.0%0.73%
-17.1%
AVRO  AVROBIO INC$33,248,000
+12.1%
1,905,3070.0%0.72%
-24.7%
MGA BuyMAGNA INTL INC$32,716,000
+42.7%
734,700
+2.3%
0.71%
-4.2%
ZGNX SellZOGENIX INC$32,717,000
-53.4%
1,211,300
-57.4%
0.71%
-68.7%
PANW  PALO ALTO NETWORKS INC$32,576,000
+40.1%
141,8370.0%0.71%
-6.0%
RCKT BuyROCKET PHARMACEUTICALS INC$32,442,000
+64.4%
1,550,000
+9.5%
0.70%
+10.3%
NOVT  NOVANTA INC$29,896,000
+33.7%
280,0000.0%0.65%
-10.2%
FVRR NewFIVERR INTL LTD$29,402,000398,299
+100.0%
0.64%
DDOG  DATADOG INC$28,607,000
+141.7%
329,0000.0%0.62%
+62.4%
STSA  SATSUMA PHARMACEUTICALS INC$28,282,000
+37.5%
983,3820.0%0.62%
-7.7%
ROL SellROLLINS INC$27,087,000
-3.0%
639,000
-17.3%
0.59%
-34.9%
TPTX NewTURNING POINT THERAPEUTICS I$24,738,000383,000
+100.0%
0.54%
VCYT  VERACYTE INC$24,087,000
+6.5%
930,0000.0%0.52%
-28.4%
HASI SellHANNON ARMSTRONG SUST INFR C$23,881,000
+38.5%
839,100
-0.7%
0.52%
-7.0%
CRNX BuyCRINETICS PHARMACEUTICALS IN$23,599,000
+69.5%
1,347,000
+42.2%
0.51%
+13.7%
QURE  UNIQURE NV$22,530,000
-5.0%
500,0000.0%0.49%
-36.2%
OKTA  OKTA INCcl a$21,625,000
+63.8%
108,0000.0%0.47%
+9.8%
CGNX NewCOGNEX CORP$21,439,000359,000
+100.0%
0.47%
AY SellATLANTICA SUSTAINABLE INFR P$21,418,000
+11.5%
736,000
-14.6%
0.47%
-25.1%
NewTRILLIUM THERAPEUTICS INC$20,605,0002,547,000
+100.0%
0.45%
KALV  KALVISTA PHARMACEUTICALS INC$20,328,000
+58.2%
1,680,0000.0%0.44%
+6.2%
MDB  MONGODB INCcl a$19,465,000
+65.8%
86,0000.0%0.42%
+11.3%
REGN  REGENERON PHARMACEUTICALS$19,271,000
+27.7%
30,9000.0%0.42%
-14.3%
SWKS BuySKYWORKS SOLUTIONS INC$18,949,000
+56.8%
148,200
+9.6%
0.41%
+5.4%
MGTA BuyMAGENTA THERAPEUTICS INC$17,721,000
+57.7%
2,359,646
+31.8%
0.38%
+5.8%
SGEN  SEATTLE GENETICS INC$17,417,000
+47.3%
102,5000.0%0.38%
-1.0%
XPO  XPO LOGISTICS INC$16,995,000
+58.5%
220,0000.0%0.37%
+6.3%
XENE  XENON PHARMACEUTICALS INC$15,977,000
+10.6%
1,274,1000.0%0.35%
-25.9%
BLU NewBELLUS HEALTH INC NEW$15,877,0001,543,000
+100.0%
0.34%
STRO BuySUTRO BIOPHARMA INC$15,411,000
+17.5%
1,985,975
+54.4%
0.34%
-21.2%
IMVT NewIMMUNOVANT INC$15,242,000625,950
+100.0%
0.33%
PHAT  PHATHOM PHARMACEUTICALS INC$14,809,000
+27.5%
450,0000.0%0.32%
-14.4%
RGEN  REPLIGEN CORP$14,710,000
+28.0%
119,0000.0%0.32%
-14.0%
DCPH  DECIPHERA PHARMACEUTICALS IN$14,512,000
+45.1%
243,0000.0%0.32%
-2.8%
CIEN NewCIENA CORP$14,461,000267,000
+100.0%
0.31%
ISRG  INTUITIVE SURGICAL INC$14,246,000
+15.1%
25,0000.0%0.31%
-22.7%
XLRN  ACCELERON PHARMA INC$13,614,000
+6.0%
142,9000.0%0.30%
-28.8%
LW SellLAMB WESTON HLDGS INC$13,336,000
-3.6%
208,600
-13.9%
0.29%
-35.3%
VRTX  VERTEX PHARMACEUTICALS INC$13,209,000
+22.0%
45,5000.0%0.29%
-18.2%
ARYA NewARYA SCIENCES ACQUISITION CO$12,592,000800,000
+100.0%
0.27%
EPIX  ESSA PHARMA INC$11,840,000
+55.0%
2,010,1690.0%0.26%
+4.0%
ALLK  ALLAKOS INC$11,498,000
+61.5%
160,0000.0%0.25%
+8.2%
ETNB Buy89BIO INC$11,460,000
+29.7%
575,000
+64.3%
0.25%
-12.9%
MKC  MCCORMICK & CO INC$10,765,000
+27.1%
60,0000.0%0.23%
-14.6%
EIDX  EIDOS THERAPEUTICS INC$10,154,000
-2.7%
213,0000.0%0.22%
-34.6%
GLPG  GALAPAGOS NVspon adr$10,062,000
+0.7%
51,0000.0%0.22%
-32.4%
CCXI NewCHEMOCENTRYX INC$10,069,000175,000
+100.0%
0.22%
XNCR  XENCOR INC$9,717,000
+8.4%
300,0000.0%0.21%
-27.2%
FENC BuyFENNEC PHARMACEUTICALS INC$9,352,000
+118.7%
1,120,000
+55.6%
0.20%
+46.0%
ARVN  ARVINAS INC$7,714,000
-16.8%
230,0000.0%0.17%
-44.0%
SNDX BuySYNDAX PHARMACEUTICALS INC$7,299,000
+193.5%
492,500
+117.3%
0.16%
+96.3%
ADCT NewADC THERAPEUTICS SA$7,021,000150,000
+100.0%
0.15%
CLDX NewCELLDEX THERAPEUTICS INC NEW$6,023,000463,335
+100.0%
0.13%
A BuyAGILENT TECHNOLOGIES INC$5,779,000
+71.3%
65,400
+38.9%
0.13%
+15.6%
ARE BuyALEXANDRIA REAL ESTATE EQ IN$5,387,000
+63.1%
33,200
+37.8%
0.12%
+9.3%
CHMA NewCHIASMA INC$5,186,000964,000
+100.0%
0.11%
PLD BuyPROLOGIS INC.$4,722,000
+49.5%
50,600
+28.8%
0.10%
+1.0%
NEE BuyNEXTERA ENERGY INC$4,587,000
+9.6%
19,100
+9.8%
0.10%
-26.5%
JKHY BuyHENRY JACK & ASSOC INC$4,472,000
+29.8%
24,300
+9.5%
0.10%
-13.4%
TER BuyTERADYNE INC$3,769,000
+128.8%
44,600
+46.7%
0.08%
+54.7%
WM BuyWASTE MGMT INC DEL$3,792,000
+35.2%
35,800
+18.2%
0.08%
-9.9%
EQIX SellEQUINIX INC$3,722,000
-14.9%
5,300
-24.3%
0.08%
-43.0%
ITT NewITT INC$3,654,00062,200
+100.0%
0.08%
FRC BuyFIRST REP BK SAN FRANCISCO C$3,413,000
+237.3%
32,200
+161.8%
0.07%
+124.2%
BuyEXACT SCIENCES CORPnote 1.000% 1/1$3,303,000
+315.5%
2,411,000
+230.3%
0.07%
+176.9%
AWK NewAMERICAN WTR WKS CO INC NEW$3,229,00025,100
+100.0%
0.07%
FHN NewFIRST HORIZON NATL CORP$3,229,000324,200
+100.0%
0.07%
CMS SellCMS ENERGY CORP$3,102,000
-24.2%
53,100
-23.8%
0.07%
-49.6%
STE NewSTERIS PLC$2,946,00019,200
+100.0%
0.06%
SHW BuySHERWIN WILLIAMS CO$2,831,000
+43.3%
4,900
+14.0%
0.06%
-3.1%
TCF NewTCF FINANCIAL CORPORATION NE$2,742,00093,200
+100.0%
0.06%
WEC SellWEC ENERGY GROUP INC$2,708,000
-23.0%
30,900
-22.6%
0.06%
-48.2%
KLAC SellKLA CORP$2,606,000
+15.5%
13,400
-14.6%
0.06%
-21.9%
ZBH BuyZIMMER BIOMET HOLDINGS INC$2,530,000
+64.7%
21,200
+39.5%
0.06%
+10.0%
ETTX  ENTASIS THERAPEUTICS HLDGS I$2,473,000
+16.0%
879,5410.0%0.05%
-21.7%
ARYAW NewARYA SCIENCES ACQUISITION CO*w exp 10/10/202$2,140,000400,000
+100.0%
0.05%
AQN SellALGONQUIN PWR UTILS CORP$1,918,000
-49.8%
148,200
-48.1%
0.04%
-66.1%
ZTS  ZOETIS INCcl a$1,946,000
+16.5%
14,2000.0%0.04%
-22.2%
 NEUROCRINE BIOSCIENCES INCnote 2.250% 5/1$1,818,000
+30.0%
1,087,0000.0%0.04%
-11.1%
MSCI NewMSCI INC$1,202,0003,600
+100.0%
0.03%
IEX SellIDEX CORP$1,169,000
-9.0%
7,400
-20.4%
0.02%
-40.5%
NDAQ NewNASDAQ INC$920,0007,700
+100.0%
0.02%
 SAREPTA THERAPEUTICS INCdbcv 1.500%11/1$882,000
+51.0%
384,0000.0%0.02%0.0%
ENTG NewENTEGRIS INC$844,00014,300
+100.0%
0.02%
BRBR NewBELLRING BRANDS INC$558,00028,000
+100.0%
0.01%
ELS SellEQUITY LIFESTYLE PPTYS INC$306,000
-85.9%
4,900
-87.0%
0.01%
-90.0%
CCOI ExitCOGENT COMMUNICATIONS HLDGS$0-3,100
-100.0%
-0.01%
CCIPRA ExitCROWN CASTLE INTL CORP NEW6.875% con pfd a$0-320
-100.0%
-0.01%
IMVTW ExitIMMUNOVANT INC*w exp 12/18/202$0-651,900
-100.0%
-0.05%
ORTX ExitORCHARD THERAPEUTICS PLCads$0-270,000
-100.0%
-0.07%
MYOV ExitMYOVANT SCIENCES LTD$0-800,000
-100.0%
-0.20%
ARYAU ExitARYA SCIENCES ACQUISITION COunit 10/04/2023$0-800,000
-100.0%
-0.29%
CTAS ExitCINTAS CORP$0-111,000
-100.0%
-0.62%
STML ExitSTEMLINE THERAPEUTICS INC$0-4,160,608
-100.0%
-0.65%
SAGE ExitSAGE THERAPEUTICS INC$0-790,000
-100.0%
-0.74%
VRNS ExitVARONIS SYS INC$0-420,000
-100.0%
-0.87%
W ExitWAYFAIR INCcall$0-250,000
-100.0%
-0.97%
XYL ExitXYLEM INC$0-793,000
-100.0%
-1.67%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2020-08-14
Signatures

The EDGAR filing(s) were signed by:

About Eventide Asset Management

Eventide Asset Management is a Boston-based investment firm that specializes in providing investment solutions to investors who are looking for long-term growth opportunities. The company was founded in 2008 by a group of experienced investment professionals who shared a common vision of creating a firm that would focus on investing in companies that are making a positive impact on society.

The company's investment philosophy is based on the belief that companies that are making a positive impact on society are more likely to be successful in the long run. Eventide's investment team conducts extensive research to identify companies that are aligned with this philosophy and have the potential to deliver strong returns over the long term.

The company's investment strategies are managed by a team of experienced professionals, including CEO Robin John, COO Finny Kuruvilla, and Chief Investment Officer, Dr. Finny Kuruvilla. The team has a proven track record of delivering strong returns to investors, and their investment strategies have been recognized by industry experts.

Eventide Asset Management offers a range of investment solutions, including mutual funds, separately managed accounts, and exchange-traded funds (ETFs). The company's funds are available to individual investors, financial advisors, and institutional investors.

Overall, Eventide Asset Management is a reputable investment firm that has a strong focus on investing in companies that are making a positive impact on society. The company's experienced investment team and proven track record make it a compelling option for investors who are looking for long-term growth opportunities.

It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
LOWES COS INC40Q3 20233.2%
PALO ALTO NETWORKS INC40Q3 20233.6%
ASML HOLDINGS NV40Q3 20231.9%
NEUROCRINE BIOSCIENCES INC40Q3 20231.1%
REPLIGEN CORP40Q3 20230.5%
VERACYTE INC38Q3 20231.5%
LAM RESEARCH CORP35Q3 20233.4%
XPO LOGISTICS INC34Q1 20233.8%
COLLEGIUM PHARMACEUTICAL INC34Q3 20232.6%
MAGNA INTL INC33Q4 20212.5%

View Eventide Asset Management's complete holdings history.

Latest significant ownerships (13-D/G)
Eventide Asset Management Q2 2020 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Cogent Biosciences, Inc.February 14, 20232,589,7783.7%
ESSA Pharma Inc.Sold outFebruary 14, 202300.0%
Freeline Therapeutics Holdings plcFebruary 14, 20235,920,7659.1%
KnowBe4, Inc.Sold outFebruary 14, 202300.0%
Praxis Precision Medicines, Inc.February 14, 20233,518,0627.5%
Prometheus Biosciences, Inc.February 14, 20231,032,9382.2%
SUTRO BIOPHARMA, INC.Sold outFebruary 14, 202300.0%
Vital Farms, Inc.Sold outFebruary 14, 202300.0%
Zymeworks Inc.Sold outFebruary 14, 202300.0%
Entasis Therapeutics Holdings Inc.February 14, 2022590,6021.2%

View Eventide Asset Management's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR/A2024-02-20
13F-HR2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14

View Eventide Asset Management's complete filings history.

Compare quarters

Export Eventide Asset Management's holdings